This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex Inc (NYSE:TFX) benefited in the first quarter from the surge in the interventional segment and other tailwinds.
泰利福公司（紐約證券交易所代碼：TFX）在第一季度受益於介入板塊的激增和其他利好因素。
UroLift sales in the physician's office could bottom out at $49 million in 2024 and the franchise will be "less of a revenue headwind" from 2025, according to Piper Sandler.
派珀·桑德勒表示，到2024年，UroLift在醫生辦公室的銷售額可能觸底至4900萬美元，從2025年起，該特許經營權將 “減少收入的不利影響”。
The Teleflex Analyst: Matt O'Brien upgraded the rating for Teleflex from Neutral to Overweight, while raising the price target from $205 to $245.
泰利福分析師：馬特·奧布賴恩將泰利福的評級從中性上調至增持，同時將目標股價從205美元上調至245美元。
The Teleflex Thesis: UroLift sales, which has prevented the stock from performing in recent quarters, should trough in the second or third quarter this year, O'Brien said in the upgrade note.
泰利福的論點：奧布萊恩在升級報告中表示，UroLift的銷售在最近幾個季度一直阻礙了該股的表現，將在今年第二或第三季度觸底。
Check out other analyst stock ratings.
查看其他分析師股票評級。
The company's sole competitor in the IABP market, Getinge is "facing significant regulatory issues with its production and sale of product, which makes about $170M worth of annual revenue potentially available to Teleflex," the analyst wrote.
該分析師寫道，作爲該公司在IABP市場的唯一競爭對手，Getinge “在產品的生產和銷售方面面臨重大的監管問題，這使得泰利福可能獲得價值約1.7億美元的年收入。”
He added that the impact of this could be felt in 2025, adding about 100-200 basis points to revenue and earnings growth.
他補充說，這種影響可能會在2025年顯現出來，使收入和收益增長增加約100-200個點子。
"We continue to get good feedback on the Barrigel product that TFX acquired last year and believe this product could grow north of 20% for several years," O'Brien further stated.
奧布萊恩進一步表示：“我們繼續獲得有關TFX去年收購的Barrigel產品的良好反饋，並相信該產品可能會在幾年內增長20％以上。”
TFX Price Action: Shares of Teleflex had risen by 1.7% to $213.92 at the time of publication on Monday.
TFX價格走勢：週一發佈時，泰利福的股價上漲了1.7％，至213.92美元。
Now Read:
現在閱讀：
- Trump Granted Partial Immunity By Supreme Court, Ruling Says 'The President Is Not Above The Law': Dissenting Justice Criticizes Mockery Of Constitution
- 特朗普被最高法院授予部分豁免權，裁決稱 “總統不能凌駕於法律之上”：持異議的法官批評對憲法的嘲弄
譯文內容由第三人軟體翻譯。